Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAMIN II: Azithromycin in Infants and Children
NCT04315272Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in malaria comparing Azithromycin with Placebo (2 arms). Primary endpoint: Malaria Status at 2 weeks. Started Aug 2020; status: completed.
02
Drugs
azithromycin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04315272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04315272.